Governance
Investors
About us
Profile
Management
Board
Scientific Advisory Board
Our Science
Strategy
Enabling Technologies
Product Classes
Pipeline
Pipeline
Nidlegy
TM
Fibromun
Darleukin
Dodekin
Dekavil
ABBV-022
Onco IX
OncoFAP
FAP-IL12
Tripokin
Press Releases & Events
Work with us
Careers
Partnering
About us
Profile
Management
Board
Scientific Advisory Board
Our Science
Strategy
Enabling Technologies
Product Classes
Pipeline
Pipeline
Nidlegy
TM
Fibromun
Darleukin
Dekavil
Dodekin
Onco IX
OncoFAP
FAP-IL12
Tripokin
Press Releases & Events
Work with us
Careers
Partnering
Investors
Investor Relations
Shareholding
IPO
Press Releases
Financial Statements
Financial Calendar
Internal Dealing
Buyback
Analyst Coverage
IR Contacts
Governance
Board of Directors
Board of Statutory Auditors
Documents & Procedures
Shareholders’ Meetings
Codice etico e Modello 231
Codice etico e Modello 231
Sustainability (ESG)
Home
$
Investors
$
Internal Dealing
Internal Dealing
Investor Relations
Shareholding
IPO
Press Releases
Internal Dealing
Buyback
Financial Statements
Financial Calendar
Analyst Coverage
IR Contacts
24/01/2022 – internal dealing
20/01/2022 – internal dealing
17/01/2022 – internal dealing
13/01/2022 – internal dealing
02/12/2021 – internal dealing
29/11/2021 – internal dealing
25/11/2021 – internal dealing
22/11/2021 – internal dealing
18/11/2021 – internal dealing
08/10/2021 – internal dealing
04/10/2021 – internal dealing
06/09/2021 – internal dealing
02/09/2021 – internal dealing
30/08/2021 – internal dealing
23/08/2021 – internal dealing
19/08/2021 – internal dealing
16/08/2021 – internal dealing
12/08/2021 – internal dealing
09/08/2021 – internal dealing
05/08/2021 – internal dealing
02/08/2021 – internal dealing
29/07/2021 – internal dealing
26/07/2021 – internal dealing
21/07/2021 – internal dealing
17/03/2021 – internal dealing
09/03/2021 – internal dealing
09/03/2021 – internal dealing
